Analyst Research Report Snapshot

Title:

BIONOMICS - BNC210 STUDIES POSITIVE

Price:

$10.00

Provider:

Edison Investment Research

Date:

04 Apr 2011

Pages:

8

Type:

AcrobatPDF

Companies referenced:

AZN.L BNO.AX NOVN.VX ROG.VX TRGT.OQ

Available for Immediate Download
Summary:

Bionomics’ investment case is now centred back on the success of the two ongoing BNC105 studies and on its ability to secure attractive partnering deals for BNC105 and BNC210. This follows the successful outcome to the two Phase Ib studies with BNC 210 and the conclusion, without a transaction, of the tender process for Start-up Australia Ventures’ large equity stake. The next significant catalyst is the interim data from Phase II studies of BNC105, due in Q2.

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.